ALBI Grade Enables Risk Stratification for Bleeding Events and Refines Prognostic Prediction in Advanced HCC Following Atezolizumab and Bevacizumab
Bernardo Stefanini,1,2 Claudia Angela Maria Fulgenzi,1,3 Bernhard Scheiner,1,4 James Korolewicz,1 Jaekyung Cheon,5 Naoshi Nishida,6 Celina Ang,7 Thomas U Marron,7 Y Linda Wu,8 Anwaar Saeed,9 Brooke Wietharn,10 Lorenza Rimassa,11,12 Angelo Pirozzi,11,12 Antonella Cammarota,12 Tiziana Pressiani,12 Mat...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-04-01
|
| Series: | Journal of Hepatocellular Carcinoma |
| Subjects: | |
| Online Access: | https://www.dovepress.com/albi-grade-enables-risk-stratification-for-bleeding-events-and-refines-peer-reviewed-fulltext-article-JHC |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|